{"transactions":[{"id":4624957,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2026-09-22T22:48:35.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":false,"shares":7438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":230563,"derivative":{"exercise_price":13.24,"expiration_date":"2035-04-21","underlying":"Common Stock","underlying_shares":7438},"source":{"system":"sec-edgar","filing":"0001916048-26-000014","document":"wk-form4_1790117313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000191604826000014/wk-form4_1790117313.xml","form_type":"4"}},{"id":4624956,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-22T22:48:35.000Z","date":"2026-09-21","kind":"sale","planned":true,"acquired":false,"shares":7438,"price":28.1172,"value":209135.7336,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.21. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":38400,"source":{"system":"sec-edgar","filing":"0001916048-26-000014","document":"wk-form4_1790117313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000191604826000014/wk-form4_1790117313.xml","form_type":"4"}},{"id":4624955,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-09-22T22:48:35.000Z","date":"2026-09-21","kind":"exercise","planned":true,"acquired":true,"shares":7438,"price":13.24,"value":98479.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."}],"balance_after":45838,"source":{"system":"sec-edgar","filing":"0001916048-26-000014","document":"wk-form4_1790117313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1933414/000191604826000014/wk-form4_1790117313.xml","form_type":"4"}},{"id":675734,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2026-08-25T21:16:45.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":false,"shares":7437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":238001,"derivative":{"exercise_price":13.24,"expiration_date":"2035-04-21","underlying":"Common Stock","underlying_shares":7437},"source":{"system":"sec-edgar","filing":"0001916048-26-000012","document":"wk-form4_1787692603.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000191604826000012/wk-form4_1787692603.xml","form_type":"4"}},{"id":675733,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-25T21:16:45.000Z","date":"2026-08-21","kind":"sale","planned":true,"acquired":false,"shares":7437,"price":25.9767,"value":193188.7179,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.82 to $26.15. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":38400,"source":{"system":"sec-edgar","filing":"0001916048-26-000012","document":"wk-form4_1787692603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000191604826000012/wk-form4_1787692603.xml","form_type":"4"}},{"id":675732,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-08-25T21:16:45.000Z","date":"2026-08-21","kind":"exercise","planned":true,"acquired":true,"shares":7437,"price":13.24,"value":98465.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."}],"balance_after":45837,"source":{"system":"sec-edgar","filing":"0001916048-26-000012","document":"wk-form4_1787692603.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000191604826000012/wk-form4_1787692603.xml","form_type":"4"}},{"id":703868,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2026-07-23T22:39:24.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":false,"shares":7438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":245438,"derivative":{"exercise_price":13.24,"expiration_date":"2035-04-21","underlying":"Common Stock","underlying_shares":7438},"source":{"system":"sec-edgar","filing":"0001916048-26-000009","document":"wk-form4_1784846362.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000191604826000009/wk-form4_1784846362.xml","form_type":"4"}},{"id":703867,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-23T22:39:24.000Z","date":"2026-07-21","kind":"sale","planned":true,"acquired":false,"shares":7438,"price":26.8735,"value":199885.093,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.53 to $27.09. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":38400,"source":{"system":"sec-edgar","filing":"0001916048-26-000009","document":"wk-form4_1784846362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000191604826000009/wk-form4_1784846362.xml","form_type":"4"}},{"id":703866,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-07-23T22:39:24.000Z","date":"2026-07-21","kind":"exercise","planned":true,"acquired":true,"shares":7438,"price":13.24,"value":98479.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."}],"balance_after":45838,"source":{"system":"sec-edgar","filing":"0001916048-26-000009","document":"wk-form4_1784846362.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000191604826000009/wk-form4_1784846362.xml","form_type":"4"}},{"id":722501,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option","published_at":"2026-06-30T22:41:19.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":false,"shares":104124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":252876,"derivative":{"exercise_price":13.24,"expiration_date":"2035-04-21","underlying":"Common Stock","underlying_shares":104124},"source":{"system":"sec-edgar","filing":"0001933414-26-000095","document":"wk-form4_1782859276.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000193341426000095/wk-form4_1782859276.xml","form_type":"4"}},{"id":722500,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T22:41:19.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":104124,"price":25.8953,"value":2696322.2172,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $25.8941 to $25.9100. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4."}],"balance_after":38400,"source":{"system":"sec-edgar","filing":"0001933414-26-000095","document":"wk-form4_1782859276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000193341426000095/wk-form4_1782859276.xml","form_type":"4"}},{"id":722499,"issuer":{"id":4432,"kind":"organization","name":"Mineralys Therapeutics, Inc.","symbol":"MLYS"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2026-06-30T22:41:19.000Z","date":"2026-06-26","kind":"exercise","planned":true,"acquired":true,"shares":104124,"price":13.24,"value":1378601.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 stock selling plan adopted on March 27, 2026."}],"balance_after":142524,"source":{"system":"sec-edgar","filing":"0001933414-26-000095","document":"wk-form4_1782859276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1916048/000193341426000095/wk-form4_1782859276.xml","form_type":"4"}},{"id":1168300,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-04-21T20:04:07.000Z","date":"2025-04-17","kind":"sale","planned":false,"acquired":false,"shares":108,"price":0.978,"value":105.624,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":370218,"source":{"system":"sec-edgar","filing":"0001628280-25-018567","document":"wk-form4_1745265839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025018567/wk-form4_1745265839.xml","form_type":"4"}},{"id":1196973,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-19T20:02:52.000Z","date":"2025-03-18","kind":"sale","planned":false,"acquired":false,"shares":2433,"price":1.487,"value":3617.871,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":370326,"source":{"system":"sec-edgar","filing":"0001628280-25-013811","document":"wk-form4_1742414564.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025013811/wk-form4_1742414564.xml","form_type":"4"}},{"id":1203646,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-17T21:16:23.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":191000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2025."}],"balance_after":191000,"derivative":{"exercise_price":1.5,"expiration_date":"2035-03-14","underlying":"Common Stock","underlying_shares":191000},"source":{"system":"sec-edgar","filing":"0001628280-25-013196","document":"wk-form4_1742246176.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025013196/wk-form4_1742246176.xml","form_type":"4"}},{"id":1203645,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-03-17T21:16:23.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":213000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2025."}],"balance_after":372759,"source":{"system":"sec-edgar","filing":"0001628280-25-013196","document":"wk-form4_1742246176.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025013196/wk-form4_1742246176.xml","form_type":"4"}},{"id":1255574,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-20T21:50:44.000Z","date":"2025-02-19","kind":"sale","planned":false,"acquired":false,"shares":239,"price":1.868,"value":446.452,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":159759,"source":{"system":"sec-edgar","filing":"0001628280-25-006802","document":"wk-form4_1740088238.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025006802/wk-form4_1740088238.xml","form_type":"4"}},{"id":1298709,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-21T21:37:56.000Z","date":"2025-01-17","kind":"sale","planned":false,"acquired":false,"shares":123,"price":2.26,"value":277.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":159998,"source":{"system":"sec-edgar","filing":"0001628280-25-002035","document":"wk-form4_1737495469.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828025002035/wk-form4_1737495469.xml","form_type":"4"}},{"id":1326519,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-12-18T21:13:45.000Z","date":"2024-12-17","kind":"sale","planned":false,"acquired":false,"shares":2234,"price":2.429,"value":5426.386,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":160121,"source":{"system":"sec-edgar","filing":"0001628280-24-051870","document":"wk-form4_1734556418.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024051870/wk-form4_1734556418.xml","form_type":"4"}},{"id":1357109,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-11-20T21:10:54.000Z","date":"2024-11-19","kind":"sale","planned":false,"acquired":false,"shares":197,"price":2.165,"value":426.505,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":162355,"source":{"system":"sec-edgar","filing":"0001628280-24-048659","document":"wk-form4_1732137047.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024048659/wk-form4_1732137047.xml","form_type":"4"}},{"id":1384027,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-10-18T20:08:47.000Z","date":"2024-10-17","kind":"sale","planned":false,"acquired":false,"shares":107,"price":2.119,"value":226.733,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":162552,"source":{"system":"sec-edgar","filing":"0001628280-24-043107","document":"wk-form4_1729282120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024043107/wk-form4_1729282120.xml","form_type":"4"}},{"id":1403484,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-09-18T20:11:57.000Z","date":"2024-09-17","kind":"sale","planned":false,"acquired":false,"shares":2608,"price":1.783,"value":4650.064,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":162659,"source":{"system":"sec-edgar","filing":"0001628280-24-040785","document":"wk-form4_1726690311.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024040785/wk-form4_1726690311.xml","form_type":"4"}},{"id":1427529,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-08-20T20:03:32.000Z","date":"2024-08-19","kind":"sale","planned":false,"acquired":false,"shares":211,"price":1.946,"value":410.606,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":165267,"source":{"system":"sec-edgar","filing":"0001628280-24-037887","document":"wk-form4_1724184206.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024037887/wk-form4_1724184206.xml","form_type":"4"}},{"id":1451140,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-19T12:30:20.000Z","date":"2024-07-17","kind":"sale","planned":false,"acquired":false,"shares":108,"price":2.587,"value":279.396,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":165478,"source":{"system":"sec-edgar","filing":"0001628280-24-032268","document":"wk-form4_1721392213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024032268/wk-form4_1721392213.xml","form_type":"4"}},{"id":1473036,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-06-20T20:16:31.000Z","date":"2024-06-18","kind":"sale","planned":false,"acquired":false,"shares":2540,"price":2.856,"value":7254.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":165586,"source":{"system":"sec-edgar","filing":"0001628280-24-029114","document":"wk-form4_1718914583.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024029114/wk-form4_1718914583.xml","form_type":"4"}},{"id":1508871,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-20T20:14:43.000Z","date":"2024-05-17","kind":"sale","planned":false,"acquired":false,"shares":192,"price":2.483,"value":476.736,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":168126,"source":{"system":"sec-edgar","filing":"0001628280-24-024346","document":"wk-form4_1716236074.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024024346/wk-form4_1716236074.xml","form_type":"4"}},{"id":1574628,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-03-15T20:35:20.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024."}],"balance_after":150000,"derivative":{"exercise_price":2.05,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001628280-24-011494","document":"wk-form4_1710534908.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024011494/wk-form4_1710534908.xml","form_type":"4"}},{"id":1574627,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-03-15T20:35:20.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024."}],"balance_after":168318,"source":{"system":"sec-edgar","filing":"0001628280-24-011494","document":"wk-form4_1710534908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828024011494/wk-form4_1710534908.xml","form_type":"4"}},{"id":1775348,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-09-21T21:06:17.000Z","date":"2023-09-20","kind":"sale","planned":false,"acquired":false,"shares":742,"price":1.245,"value":923.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":68318,"source":{"system":"sec-edgar","filing":"0001628280-23-032795","document":"wk-form4_1695330364.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023032795/wk-form4_1695330364.xml","form_type":"4"}},{"id":1800661,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-21T20:32:01.000Z","date":"2023-08-18","kind":"sale","planned":false,"acquired":false,"shares":243,"price":1.414,"value":343.602,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":69060,"source":{"system":"sec-edgar","filing":"0001628280-23-030129","document":"wk-form4_1692649904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023030129/wk-form4_1692649904.xml","form_type":"4"}},{"id":1825683,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-07-20T20:38:28.000Z","date":"2023-07-19","kind":"sale","planned":false,"acquired":false,"shares":106,"price":1.585,"value":168.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":69303,"source":{"system":"sec-edgar","filing":"0001628280-23-025248","document":"wk-form4_1689885499.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023025248/wk-form4_1689885499.xml","form_type":"4"}},{"id":1846410,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-06-22T20:45:17.000Z","date":"2023-06-21","kind":"sale","planned":false,"acquired":false,"shares":603,"price":1.483,"value":894.249,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":69409,"source":{"system":"sec-edgar","filing":"0001628280-23-023157","document":"wk-form4_1687466704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023023157/wk-form4_1687466704.xml","form_type":"4"}},{"id":1886756,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-18T20:07:12.000Z","date":"2023-05-17","kind":"sale","planned":false,"acquired":false,"shares":219,"price":1.624,"value":355.656,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":70012,"source":{"system":"sec-edgar","filing":"0001628280-23-018872","document":"wf-form4_168444041471189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023018872/wf-form4_168444041471189.xml","form_type":"4"}},{"id":1916418,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-04-20T20:12:54.000Z","date":"2023-04-19","kind":"sale","planned":false,"acquired":false,"shares":115,"price":1.278,"value":146.97,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":70231,"source":{"system":"sec-edgar","filing":"0001628280-23-012265","document":"wf-form4_168202156208560.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023012265/wf-form4_168202156208560.xml","form_type":"4"}},{"id":1944318,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-20T20:16:20.000Z","date":"2023-03-17","kind":"sale","planned":false,"acquired":false,"shares":526,"price":1.7823,"value":937.4898,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of restricted stock units."}],"balance_after":70346,"source":{"system":"sec-edgar","filing":"0001628280-23-008609","document":"wf-form4_167934336969120.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023008609/wf-form4_167934336969120.xml","form_type":"4"}},{"id":1952078,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-15T13:22:37.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":94500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service."}],"balance_after":94500,"derivative":{"exercise_price":4.02,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":94500},"source":{"system":"sec-edgar","filing":"0001628280-23-007970","document":"wf-form4_167888654616429.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023007970/wf-form4_167888654616429.xml","form_type":"4"}},{"id":1952077,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-15T13:22:37.000Z","date":"2023-03-14","kind":"grant","acquired":true,"shares":22300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service."}],"balance_after":70872,"source":{"system":"sec-edgar","filing":"0001628280-23-007970","document":"wf-form4_167888654616429.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023007970/wf-form4_167888654616429.xml","form_type":"4"}},{"id":1963127,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-03-08T21:22:06.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":5090,"price":5.055,"value":25729.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on vested shares of performance-based restricted stock units."}],"balance_after":48572,"source":{"system":"sec-edgar","filing":"0001628280-23-006992","document":"wf-form4_167831051271071.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828023006992/wf-form4_167831051271071.xml","form_type":"4"}},{"id":2134662,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-10-19T20:11:33.000Z","date":"2022-10-18","kind":"sale","acquired":false,"shares":107,"price":7.69,"value":822.83,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units."}],"balance_after":53662,"source":{"system":"sec-edgar","filing":"0001628280-22-026631","document":"wf-form4_166621025881204.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022026631/wf-form4_166621025881204.xml","form_type":"4"}},{"id":2154015,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-09-20T20:09:20.000Z","date":"2022-09-19","kind":"sale","acquired":false,"shares":255,"price":6.921,"value":1764.855,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units."}],"balance_after":53769,"source":{"system":"sec-edgar","filing":"0001628280-22-025218","document":"wf-form4_166370453726031.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022025218/wf-form4_166370453726031.xml","form_type":"4"}},{"id":2169883,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-31T20:14:37.000Z","date":"2022-08-31","kind":"purchase","acquired":true,"shares":1000,"price":7.46,"value":7460.0,"ownership":{"direct":true},"balance_after":54024,"source":{"system":"sec-edgar","filing":"0001628280-22-024059","document":"wf-form4_166197686284070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022024059/wf-form4_166197686284070.xml","form_type":"4"}},{"id":2179452,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-08-18T20:10:28.000Z","date":"2022-08-17","kind":"sale","acquired":false,"shares":199,"price":6.815,"value":1356.185,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units."}],"balance_after":53024,"source":{"system":"sec-edgar","filing":"0001628280-22-023250","document":"wf-form4_166085341182828.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022023250/wf-form4_166085341182828.xml","form_type":"4"}},{"id":2204530,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-07-20T20:27:07.000Z","date":"2022-07-19","kind":"sale","acquired":false,"shares":431,"price":6.582,"value":2836.842,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units."}],"balance_after":53223,"source":{"system":"sec-edgar","filing":"0001628280-22-019179","document":"wf-form4_165834881315059.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022019179/wf-form4_165834881315059.xml","form_type":"4"}},{"id":2225296,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-06-21T20:06:39.000Z","date":"2022-06-17","kind":"sale","acquired":false,"shares":256,"price":4.9,"value":1254.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units."}],"balance_after":53654,"source":{"system":"sec-edgar","filing":"0001628280-22-017640","document":"wf-form4_165584197584984.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022017640/wf-form4_165584197584984.xml","form_type":"4"}},{"id":2237648,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-06-09T20:46:53.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Such award shall vest upon obtaining approval for cardiovascular risk reduction into the U.S. label."}],"balance_after":52000,"derivative":{"exercise_price":6.2,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001628280-22-016703","document":"wf-form4_165480759498402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022016703/wf-form4_165480759498402.xml","form_type":"4"}},{"id":2265540,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-05-18T20:30:00.000Z","date":"2022-05-17","kind":"sale","acquired":false,"shares":196,"price":5.981,"value":1172.276,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units."}],"balance_after":53910,"source":{"system":"sec-edgar","filing":"0001628280-22-014762","document":"wf-form4_165290519246954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022014762/wf-form4_165290519246954.xml","form_type":"4"}},{"id":2330634,"issuer":{"id":30796,"kind":"organization","name":"Esperion Therapeutics, Inc.","symbol":"ESPR"},"owners":[{"id":19772,"kind":"person","name":"Warren Eric","position":1,"cik":"0001916048","reported_name":"Warren Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2022-03-16T21:11:05.000Z","date":"2022-03-14","kind":"grant","acquired":true,"shares":13000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The awards will vest quarterly over four years beginning on March 15, 2022."}],"balance_after":54106,"source":{"system":"sec-edgar","filing":"0001628280-22-006410","document":"wf-form4_164746503326063.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434868/000162828022006410/wf-form4_164746503326063.xml","form_type":"4"}}]}